SCHEMBL30737893

SCHEMBL30737893

Clc1ccc(Nc2nccc3ccoc23)cn1

nearest known ligand 0.51

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ASIC3 Q9UHC3 1/20 0.51
TNF P01375 2/20 0.45
GRM4 Q14833 1/20 0.43
PIK3CA P42336 1/20 0.43
KCNQ3 O43525 5/20 0.36
KCNQ2 O43526 5/20 0.36
KCNQ1 P51787 3/20 0.36
TRPA1 O75762 2/20 0.36
SCN5A Q14524 1/20 0.36
FADS1 O60427 1/20 0.35
PIN1 Q13526 1/20 0.34
JAK2 O60674 4/20 0.34
JAK1 P23458 4/20 0.34
KCNE1 P15382 2/20 0.33
GRM5 P41594 1/20 0.33
BACE1 P56817 1/20 0.33
NOTUM Q6P988 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26928464 1.00 ASIC3 (0.51) ASIC3TNFGRM4PIK3CAKCNQ3
Formic Acid SCHEMBL30738085 0.92 ASIC3 (0.45) ASIC3TNFGRM4PIK3CAKCNQ3
Formic Acid SCHEMBL26928765 0.92 ASIC3 (0.45) ASIC3TNFGRM4PIK3CAKCNQ3
SCHEMBL26928697 0.77 FADS1 (0.60) TNFGRM4PIK3CAKCNQ3KCNQ2
SCHEMBL30738032 0.77 FADS1 (0.60) TNFGRM4PIK3CAKCNQ3KCNQ2
SCHEMBL26928701 0.75 GRM4 (0.47) TNFGRM4PIK3CAKCNQ3KCNQ2
SCHEMBL26928896 0.73 GRM4 (0.59) TNFGRM4PIK3CA
SCHEMBL26929269 0.73 BACE1 (0.43) TNFGRM4PIK3CAKCNQ3KCNQ2
SCHEMBL30824385 0.72 TNF (0.51) TNFGRM4PIK3CAKCNQ3KCNQ2
SCHEMBL30738201 0.72 TNF (0.44) TNFGRM4PIK3CAKCNQ3KCNQ2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4536356-A1 PYRIDINAMINE DERIVATIVES AND THEIR USE AS POTASSIUM CHANNEL MODULATORS Xenon Pharmaceuticals Inc. (CA) 2025-04-16 EP claimed
WO-2023239729-A1 PYRIDINAMINE DERIVATIVES AND THEIR USE AS POTASSIUM CHANNEL MODULATORS XENON PHARMACEUTICALS INC. (CA) 2023-12-14 WO claimed
EP-4536356-A1 PYRIDINAMINE DERIVATIVES AND THEIR USE AS POTASSIUM CHANNEL MODULATORS Xenon Pharmaceuticals Inc. (CA) 2025-04-16 EP disclosed
WO-2023239729-A1 PYRIDINAMINE DERIVATIVES AND THEIR USE AS POTASSIUM CHANNEL MODULATORS XENON PHARMACEUTICALS INC. (CA) 2023-12-14 WO disclosed